In recent weeks, several major institutional investors have taken new positions in BWX Technologies (NYSE: BWXT), the leading North American manufacturer of specialized nuclear components. Among the new buyers are HSBC Holdings, with 9,133 shares, Alyeska Investment Group, with 255,328 shares valued at approximately $68 million, and Kingsview Wealth Management. This convergence of capital sends a clear signal about where institutional money is positioning itself within the nuclear sector.
BWXT is not a bet on the future — it is a company generating cash today. In 2025, it reported revenues of $3.2 billion, up 18% year-over-year, with net income of $329 million. Its order backlog reached $7.3 billion, a 50% annual increase, driven by multi-year contracts tied to naval propulsion and specialty materials production. For 2026, the company is guiding for revenues of approximately $3.75 billion, with non-GAAP EPS expected in the range of $4.55 to $4.70 per share.
The historical core of BWXT’s business is supplying the U.S. Navy: the company designs and manufactures nuclear reactors powering submarines and aircraft carriers, and manages their ongoing maintenance. However, growth is accelerating on the commercial and SMR front. In the first quarter of 2026, revenues from the commercial operations segment more than doubled, driven by demand for components, field services, fuel management, and engineering. In April, BWXT acquired Precision Components Group, adding over 500,000 square feet of heavy manufacturing capacity and a workforce of more than 400 skilled employees. This marks the first concrete step toward building a domestic American supply chain for next-generation civilian reactors.
On the defense side, the U.S. Army selected BWXT to install its 20-megawatt reactor — the BWXT Advanced Nuclear Reactor (BANR) — at Fort Campbell in Kentucky, as part of the Janus program. Construction is expected to begin by late 2028, with operational startup targeted for the early 2030s. The project moves BANR technology from the development phase into active deployment on a working military base. The global SMR market was valued at $5.96 billion in 2025 and is projected to reach $8.77 billion by 2034.
The stock has gained approximately 90% over the past twelve months. Analysts have revised their price targets upward to around $274, citing a commercial book-to-bill ratio above 2x, new long-term fuel contracts, and wins in SMR component supply. At current levels, the valuation looks attractive relative to peers — the forward price-to-sales multiple sits below 5x, compared to a sector average exceeding 12x. With strong operational execution, a growing backlog, and a dual footprint spanning defense and civilian nuclear, BWX Technologies stands out as one of the most solid assets in the entire American nuclear renaissance supply chain.
